ANBITION
ANBITION provides solutions for angiogenesis, pathological angiogenesis, anti-angiogenic therapy, and synthetic peptides. They offer inquiries through phone calls and emails.
ANBITION
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2018-01-01
Address:
Naples, Campania, Italy
Country:
Italy
Website Url:
http://www.anbition.it
Status:
Active
Contact:
+39 081 2395462
Email Addresses:
[email protected]
Technology used in webpage:
Italian Server Location
Similar Organizations
Enterprise Therapeutics
A UK-based developer of drugs to treat respiratory diseases
ImmuSmol
ImmuSmol develops small molecule antibodies for research, diagnostics, and therapy.
Micro Therapeutics
Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases.
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Polygon Therapeutics
Polygon Therapeutics develops innovative biomedicines for the treatment of cardiovascular diseases.
Spital Lachen
Spital Lachen is a hospital that offers health diagnostics, therapy, and general care services.
Current Employees Featured
Founder
Official Site Inspections
http://www.anbition.it
- Host name: webx1252.aruba.it
- IP address: 89.46.107.226
- Location: Arezzo Italy
- Latitude: 43.4631
- Longitude: 11.8783
- Timezone: Europe/Rome
- Postal: 52100

More informations about "ANBITION"
anbition - ANgiogenesis inhiBITION
ANBITION s.r.l., is an innovative start-up company registered at the business register of Naples, Italy REA number: NA-992795. Read More. Pathological angiogenesis In 1971, Judah Folkman published the first hypothesis that โฆSee details»
Mission - anbition
ANBITION s.r.l., is an innovative start-up company registered at the business register of Naples, Italy (REA number: NA-992795) ANBITION activities are focused on developing new โฆSee details»
Contact us - anbition
ANBITION s.r.l Via Alessandro Manzoni 1, 80123 Napoli, Italy VAT number: 08891581210 Ph: +39 081 2395462 Fax: +39 081 2397208 certified electronic mail: [email protected] email: โฆSee details»
ANBITION - Crunchbase Company Profile & Funding
ANBITION provides solutions for angiogenesis, pathological angiogenesis, anti-angiogenic therapy, and synthetic peptides. They offer inquiries through โฆSee details»
ANBITION - Contacts, Employees, Board Members, Advisors
ANBITION develops new molecules and technologies for treating or diagnosing angiogenesis-related diseases.See details»
Anbition Srl (Italy) Funding - medicalstartups.org
Website: https://www.anbition.it Anbition Srl is developing new molecules and technologies for treating or diagnosing angiogenesis-related diseases MedicalStartupsSee details»
Anbition S.R.L. - US Patent and Trademark Search
Patent applications and USPTO patent grants for Anbition S.R.L..The latest application filed is for "peptides and medical uses thereof". Company Profile. 0.0.2. Anbition S.R.L. - Napoli IT ...See details»
ANBITION - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ANBITION develops new molecules and technologies for treating or diagnosing angiogenesis-related diseases.See details»
ANBITION s.r.l | Institution outputs | Nature Index
ANBITION s.r.l, Italy Time frame: 1 January 2023 - 31 December 2023 Profile. The positions in the table below reflect the ANBITION s.r.l's position overall, domestically, within their sector, โฆSee details»
People - anbition
The founders of ANBITION are Davide Rosiello, Sandro De Falco and Menotti Ruvo. Menotti will bring to ANBITION his longstanding experience, matured in both, public and pharmaceutical โฆSee details»
Anbition Srl di Napoli - Elenco Aziende Italia
Dati finanziari di Anbition Srl: Lโultimo bilancio depositato da Anbition Srl nel registro delle imprese corrisponde allโanno 2023 e riporta un range di fatturato di 0.0. Il fatturato di Anbition Srl โฆSee details»
Anbition, i farmaci del futuro nella cura delle malattie oculari
Jan 11, 2024 Anbition, che insieme a BIOVIIIX ha ottenuto importanti riconoscimenti, ha brevettato i due farmaci in tutto il mondo ma dalla scoperta di una probabile cura โฆSee details»
ANBITION srl.:Company Profile & Technical Research,Competitor โฆ
ANBITION srl. was founded in 2018. ANBITION srl. has a total of 17 patents . Login to view all basic info. Data Snapshot. 17. Patent. 1. News. High Related Markets. Mentioned companies โฆSee details»
Our History - anbition
ANBITION borns in early 2018 when Sandro De Falco and Menotti Ruvo, researchers with a thirty years experience in biotechnology applied research, met Davide Rosiello, CEO and founder of โฆSee details»
Home - Enbition
Versimpel je administratie We brengen jouw administratie en processen op orde.Zo kost het jou minder tijd en heb je altijd actueel inzicht in je financiële situatie. Rapporteer eenvoudig Voldoe โฆSee details»
www.anbition.com
Www.anbition.comSee details»
What is ambition? - routeicr.com
Sep 19, 2024 Without ambition, an organization risks stagnation and losing its competitive edge. Moreover, a challenging ambition motivates the employees and partners of your organization โฆSee details»
ANBITION - Crunchbase
ANBITION develops new molecules and technologies for treating or diagnosing angiogenesis-related diseases.See details»
Collaborations - anbition
Institute of Genetics and Biophysics โAdriano Buzzati-Traversoโ, National Research Council, Napoli, Italy IGB-CNR Angiogenesis LAB Institute of Biostructures and Bioimaging, National โฆSee details»
If Anthropic Succeeds, a Nation of Benevolent AI Geniuses Could โฆ
1 day ago The brother goes on vision quests. The sister is a former English major. Together, they defected from OpenAI, started Anthropic, and built (they say) AIโs most upstanding โฆSee details»